Cytochalasin B interferes with conformational changes of the human erythrocyte glucose transporter induced by internal and external sugar binding.
To gain insight into the mechanism of facilitated sugar transport and possible mechanisms by which glucose transporter intrinsic activity might be altered, we have investigated conformational changes of the human erythrocyte glucose transporter induced by internal and external sugar binding and by the transporter inhibitor, cytochalasin B. Changes in the ability of thermolysin to digest glucose transporters present in erythrocyte ghosts were used to monitor conformational changes of the glucose transporter. The degree of protease digestion was determined by the amount of undigested glucose transporter remaining after the protease treatment, as assessed in Western blots using the glucose transporter specific monoclonal antibody 7F7.5. D-Glucose, the physiological substrate of the transporter, increased the transporter's susceptibility to cleavage by thermolysin. Nontransportable glucose analogues which bind specifically to either an internal or external glucose transporter sugar binding site also altered susceptibility of the transporter to thermolysin. Both methyl and propyl glucoside, which preferentially bind the internal sugar site, increased thermolysin susceptibility of the glucose transporter in a manner similar to that of D-glucose. In contrast, 4,6-O-ethylideneglucose, which preferentially binds the external sugar site, protected the transporter from thermolysin digestion. These results suggest that sugar binding to internal and external sugar sites induces distinct conformational changes and that the observed D-glucose effect on the susceptibility of the glucose transporter to thermolysin is due to D-glucose at equilibrium predominantly forming a complex with the internal sugar site. The protection from cleavage by thermolysin caused by external sugar binding is attenuated by the addition of an internally binding sugar.(ABSTRACT TRUNCATED AT 250 WORDS)
King
A P
AP
Department of Physiology, University of Michigan Medical School, Ann Arbor 48109-0622.
Tai
P K
PK
Carter-Su
C
C
D001692:Biological Transport / Q000187:drug effects; D003571:Cytochalasin B / Q000494:pharmacology*; D004910:Erythrocyte Membrane / Q000737:chemistry* / Q000187:drug effects; D005947:Glucose / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D006868:Hydrolysis; D009004:Monosaccharide Transport Proteins / Q000737:chemistry* / Q000187:drug effects; D011485:Protein Binding / Q000187:drug effects; D011487:Protein Conformation / Q000187:drug effects; D013820:Thermolysin / Q000494:pharmacology
D009004:Monosaccharide Transport Proteins; D003571:Cytochalasin B; D013820:Thermolysin; D005947:Glucose